The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

GSK FINANCIAL STATEMENTS

GSK plc — balance sheet, income statement and cash flow trends

GSKGSK plc

🇬🇧 UK · LSE · Healthcare · Drug Manufacturers - General

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
010 B20 B30 B202020212023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue33.2 B £Gross Profit24.3 B £ · 73%Operating Income8 B £ · 24%Pre-tax Income5.9 B £ · 18%Net Income to Owners4.8 B £ · 15%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue33.2 B £+5.0%
Gross Profit24.3 B £+7.3%
Operating Income8 B £+47.0%
EBITDA11 B £+20.6%
Net Income to Owners4.8 B £+40.8%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
025 B50 B75 B202020212023202420252026

Capital Structure

Q2 2026
Total Assets61.7 B
  • Equity17.6 B £28%
  • Current Liabilities21.5 B £35%
  • Long-term Liabilities23 B £37%

Key Figures

YoY change
Total Assets61.7 B £+4.2%
Total Liabilities44.6 B £-0.8%
Total Equity17.6 B £+19.3%
Cash & ST Investments3.1 B £-14.2%
Total Debt18.2 B £+5.1%
Net Debt15.1 B £—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
02.5 B5 B7.5 B202020212023202420252026

Cash Flow Bridge

Q2 2026 · TTM
02.5 B5 B7.5 B8 B £Operating-6.3 B £Investing-2.1 B £Financing-436 M £Net Change

Key Figures

YoY change
Operating Cash Flow8 B £+3.3%
Capital Expenditures2.2 B £-11.8%
Free Cash Flow5.8 B £+10.6%
Dividends Paid2.7 B £+7.0%

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on GSK

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 4, 26. This content is for informational purposes only and is not investment advice.